Celebrex comes up in 3 chapters across 3 episodes of The No Agenda Show, from November 2010 to July 2013.
Pharmaceutical Advertising, Celebrex vs Cymbalta Side Effects
A comparison of television advertisements for Celebrex and Cymbalta focuses on the increasingly dire side effects listed in the disclaimers. The hosts note that Celebrex now explicitly mentions the risk of death, while Cymbalta lists suicidal thoughts and liver failure. They track the annual revenue of both drugs to see if "scarier" ads correlate with higher sales.
Pharmaceutical Advertising and Side Effect Comparisons
A comparison of commercials for Celebrex and Cymbalta reveals a trend of increasingly severe side effect warnings, including the explicit mention of death. Despite the warnings, both drugs generate billions in annual revenue, supporting a theory that "scary" side effects do not deter sales.
Celebrex Commercial Deconstruction, Pharmaceutical Risks
A new Celebrex advertisement is deconstructed for its rapid-fire delivery of life-threatening side effects. The commercial warns that the drug, used for arthritis, can cause heart attacks, strokes, and fatal stomach bleeding. The hosts highlight the absurdity of the "balance the benefits with the risks" messaging, suggesting that the risk of death outweighs the benefit of pain relief.
For AI agents: this site has a plain-text version made for you. This page in markdown: https://search.noagendashow.net/topic/celebrex.md. Search every episode transcript: https://search.noagendashow.net/search.md?q={query}. How to use the site, with timestamped links to quote: https://search.noagendashow.net/llms.txt.
